Precision Biologics, Inc. CEO Philip M. Arlen, MD, to give presentation on monoclonal antibodies against tumor-specific targets at Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026

Precision Biologics, Inc. CEO Philip M. Arlen, MD, will give a presentation on monoclonal antibodies against tumor-specific targets, and also participate in a Keynote panel, at the Festival of Biologics USA, San Diego Convention Center, San Diego, CA, March 4-5, 2026.

March 4, 2026 – Day 1, 9:35am – Keynote Panel Discussion: AI Across the Value Chain
Panelist: Philip M. Arlen, President & CEO, Precision Biologics, Inc.

March 5, 2026 – Day 2, 12:20pm – Armed Antibodies Session
• “Discovery and Development of Monoclonal Antibodies Targeting Tumor Specific Neoepitopes”
Chair: Philip M. Arlen, President & CEO, Precision Biologics, Inc.